Scholar Rock Holding Corp (SRRK)
26.67
-1.19
(-4.27%)
USD |
NASDAQ |
Nov 21, 16:00
26.69
+0.02
(+0.07%)
After-Hours: 20:00
Scholar Rock Enterprise Value: 2.408B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 2.408B |
| November 20, 2024 | 2.519B |
| November 19, 2024 | 2.519B |
| November 18, 2024 | 2.381B |
| November 15, 2024 | 2.391B |
| November 14, 2024 | 2.485B |
| November 13, 2024 | 2.474B |
| November 12, 2024 | 2.407B |
| November 11, 2024 | 2.546B |
| November 08, 2024 | 2.633B |
| November 07, 2024 | 2.621B |
| November 06, 2024 | 2.635B |
| November 05, 2024 | 2.543B |
| November 04, 2024 | 2.455B |
| November 01, 2024 | 2.524B |
| October 31, 2024 | 2.526B |
| October 30, 2024 | 2.667B |
| October 29, 2024 | 2.755B |
| October 28, 2024 | 2.709B |
| October 25, 2024 | 2.661B |
| October 24, 2024 | 2.578B |
| October 23, 2024 | 2.481B |
| October 22, 2024 | 2.586B |
| October 21, 2024 | 2.666B |
| October 18, 2024 | 2.720B |
| Date | Value |
|---|---|
| October 17, 2024 | 2.554B |
| October 16, 2024 | 2.531B |
| October 15, 2024 | 2.490B |
| October 14, 2024 | 2.488B |
| October 11, 2024 | 2.306B |
| October 10, 2024 | 2.273B |
| October 09, 2024 | 2.135B |
| October 08, 2024 | 2.273B |
| October 07, 2024 | 2.656B |
| October 04, 2024 | 505.24M |
| October 03, 2024 | 477.21M |
| October 02, 2024 | 499.63M |
| October 01, 2024 | 507.64M |
| September 30, 2024 | 552.49M |
| September 27, 2024 | 558.26M |
| September 26, 2024 | 551.86M |
| September 25, 2024 | 548.66M |
| September 24, 2024 | 551.06M |
| September 23, 2024 | 553.46M |
| September 20, 2024 | 611.09M |
| September 19, 2024 | 540.66M |
| September 18, 2024 | 521.45M |
| September 17, 2024 | 519.05M |
| September 16, 2024 | 507.84M |
| September 13, 2024 | 545.46M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-45.07M
Minimum
Jul 01 2022
2.755B
Maximum
Oct 29 2024
590.36M
Average
392.02M
Median
Enterprise Value Benchmarks
| Cytokinetics Inc | 5.270B |
| Regeneron Pharmaceuticals Inc | 74.00B |
| Ocugen Inc | 226.64M |
| Mirum Pharmaceuticals Inc | 2.110B |
| NeuroBo Pharmaceuticals Inc | -1.421M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -64.48M |
| Total Expenses (Quarterly) | 64.78M |
| EPS Diluted (Quarterly) | -0.66 |
| Earnings Yield | -8.81% |
| Normalized Earnings Yield | -11.40 |